血管生成不能预测局部晚期乳腺癌患者对阿霉素单一疗法的临床反应。 - Suppr | 超能文献

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.

作者信息

Paulsen T, Aas T, Børresen A L, Varhaug J E, Lønning P E, Akslen L A

出版信息

Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a.

DOI:10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.血管生成不能预测局部晚期乳腺癌患者对阿霉素单一疗法的临床反应。

Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a.

2

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.TP53基因改变和c-erbB-2表达对局部晚期乳腺癌多柔比星治疗反应的影响。

Cancer Res. 2001 Mar 15;61(6):2505-12.

3

[Evaluation of the angiogenic process in breast carcinoma--correlations with cancer aggressiveness].[乳腺癌血管生成过程的评估——与癌症侵袭性的相关性]

Rev Med Chir Soc Med Nat Iasi. 2004 Jul-Sep;108(3):657-61.

4

Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?

Ann Oncol. 2005 Mar;16(3):516-7. doi: 10.1093/annonc/mdi078. Epub 2005 Jan 10.

5

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.特定的P53突变与乳腺癌患者对阿霉素的原发耐药性相关。

Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811.

6

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.拓扑异构酶IIα及其他预后因素对晚期乳腺癌表柔比星化疗的预测价值

Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377.

7

Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.乳腺癌中的血管生成标志物——用于确定抗血管生成药物优先级的潜在有用工具。

Asian Pac J Cancer Prev. 2013;14(12):7651-6. doi: 10.7314/apjcp.2013.14.12.7651.

8

Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome.乳腺癌的诱导化疗：预测标志物及其与预后的关系。

Int J Oncol. 2003 Jun;22(6):1319-25.

9

Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.p53、血管生成及其他传统特征在可手术乳腺癌中的预后意义：对淋巴结阳性和阴性患者的亚组分析

Int J Oncol. 1998 May;12(5):1117-25. doi: 10.3892/ijo.12.5.1117.

10

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960.

引用本文的文献

1

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.肾小球样微血管增生与乳腺癌对化疗无反应有关。

Br J Cancer. 2011 Jun 28;105(1):9-12. doi: 10.1038/bjc.2011.203. Epub 2011 Jun 14.

2

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.

Br J Cancer. 2002 Jun 17;86(12):1905-8. doi: 10.1038/sj.bjc.6600325.

3

Independent prognostic importance of microvessel density in endometrial carcinoma.微血管密度在子宫内膜癌中的独立预后意义。

Br J Cancer. 1998 Apr;77(7):1140-4. doi: 10.1038/bjc.1998.189.